Прогностическое значение исходного уровня хромогранина а у больных НЭО
G S Yemelyanova, Vera A. Gorbunova, Н В Любимова et al. · Российский биотерапевтический журнал · 2014
The purpose of this research the study of the prognostic value of baseline CgA in the blood of patients with common secreting highly differentiated NETs receiving biotherapy.The results of application of biotherapy in 69 patients with highly differentiated NETs common. Step method of increasing the value of chromogranin A, starting with the upper limit of normal, was allocated the lowest level at which the obtained differences in progression-free survival were of statistically significant character, he was 200 U / 1.In accordance with the data obtained, we can conclude that patients with baseline ( prior to treatment ) Blood CgA below 200 IU / 1 would be the best estimate for the TTP.
Cited by 0 works.